Sort by   'shares'

Transplants and Risk Adapted Maintenance in Myeloma Treatment

The treatment paradigm for myeloma patients has changed in the last decade with important advancements such as proteasome inhibitors, IMiDS, antibodies and risk-adapted maintenance. How a patient responds to therapy can be used to determine how long the maintenance or…